The University of Chicago Header Logo

Connection

Kerstin Stenson to In Situ Hybridization, Fluorescence

Back to Details
This is a "connection" page, showing publications Kerstin Stenson has written about In Situ Hybridization, Fluorescence.
Kerstin Stenson
Connection Strength
0.025
In Situ Hybridization, Fluorescence
  1. Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck. Oral Oncol. 2012 Sep; 48(9):887-92.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.